CBIO
Crescent Biopharma, Inc.
NASDAQ: CBIO · HEALTHCARE · BIOTECHNOLOGY
$22.37
+6.83% today
Updated 2026-04-30
Market cap
$755.46M
P/E ratio
—
P/S ratio
69.67x
EPS (TTM)
$-12.81
Dividend yield
—
52W range
$9 – $29
Volume
0.2M
Crescent Biopharma, Inc. (CBIO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |